Half-life concepts, explained like a careful reader is in the room.

How to use the evidence guides

Start here when a profile gives you a half-life number and you want to know what kind of claim that number can support. The guides explain why half-life is not the same as duration, why repeated exposure changes the curve, and why two credible studies can report different values for the same substance.

The articles stay focused on pharmacokinetic interpretation. They do not provide dosing, treatment, testing, impairment, or safety advice. Their purpose is to help a reader understand the model before comparing individual profile pages or reading the original sources.

Recommended reading order

1. Read the half-life definition first so the 50% concept is clear.
2. Review clearance, distribution, route, and formulation to understand what shapes a source value.
3. Use the duration, metabolite, variability, and nonlinear kinetics pages to avoid overreading one number.
4. Open the study-reading, source-quality, methodology, and sources pages when you want to audit how entries are built.

Guides and references

• Clearance and volume of distribution
  Why half-life depends on both how widely a substance distributes and how efficiently it is cleared.
• Bioavailability, route, and formulation
  How oral, inhaled, injected, transdermal, immediate-release, and extended-release forms change source interpretation.
• Active metabolites and parent compounds
  Why parent-drug curves may not describe metabolites, downstream effects, accumulation, or testing analytes.
• What half-life actually tells you
  A plain-language field guide to the 50% idea, the curve it creates, and the questions one number cannot answer.
• The half-life math behind the curve
  The first-order equation, a worked example, and the reason exponential decay never behaves like a countdown timer.
• Half-life vs duration
  Why concentration, subjective effects, impairment, and detection are related concepts but not interchangeable ones.
• Terminal vs effective half-life
  How the late slope of a curve can differ from the practical half-life used to discuss accumulation and repeated exposure.
• Steady state and accumulation
  How overlapping exposures change the story and why the 4 to 5 half-life rule is useful but easy to overread.
• Why half-life varies between people and studies
  A practical checklist for reading population, route, formulation, sampling, and modeling differences in source material.
• First-order vs nonlinear kinetics
  When the simple half-life curve is useful, and when saturation or multiphase behavior makes one value unstable.
• Detection windows vs half-life
  Why detection questions depend on analytes, specimen type, cutoffs, and testing methods rather than a simple curve.
• Reading labels and source quality
  How to weigh FDA labels, DailyMed records, PubMed papers, PubChem records, and review articles.
• How to read a pharmacokinetic study
  A reader-friendly way to scan study designs, concentration-time charts, endpoints, and limitations without getting lost.
• Methodology
  How HalfLifeDB chooses representative values, builds curves, and describes source limitations.

What the evidence guides do not cover

HalfLifeDB does not estimate whether someone is impaired, whether a substance is safe to combine with another substance, or whether a laboratory test will be positive or negative. Those questions require clinical, toxicology, legal, or laboratory context that a simple educational model cannot supply.

Why this section exists

A smooth curve can look more certain than the evidence behind it. These guides slow the reading process down: identify the measured analyte, study population, route, formulation, sampling window, and model before carrying a half-life estimate into another context.

If a substance profile feels too compressed, these articles explain the larger pharmacokinetic concepts behind the chart and point back to the sources a careful reader should check.